Remarkably, Tet1 expression has been found to be reduced in a wide range of solid cancers, such as melanoma, prostate, lung, and liver tumors (57, 58)—where also GSNOR mRNA seems to be downregulated—and to correlate with advanced cancer stage, nodal metastases, and poor survival rate in breast cancer patients (59). Here, TET1 is linked to cancer.